HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics

Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date: Thursday, January 30, 2020

Time: 2:00pm-3:00pm (Eastern Time)

Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WC2922-013020 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – “HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid, Thursday, January 30, 2020, please visit TCEO and follow these 9 Simple Steps by March 2, 2020.

In order to receive continuing education (CE) for WD2922-013020 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars “HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Thursday, January 30, 2020 (Web on Demand), please visit TCEO and follow these 9 Simple Steps by March 3, 2022.

Overview

An estimated 3% to 4% of adults in the United States use opioids long-term to help manage chronic pain. Evidence is accumulating that the use of non-opioid strategies may provide equal or more effective pain relief with lower risks than opioids for most patients with chronic pain. Also, the benefits of long-term opioid therapy often diminish over time while the risks may not.

In October, the U.S. Department of Health and Human Services (HHS) released a guide to help clinicians reduce risks and improve outcomes related to opioid dose reduction or discontinuation among patients prescribed opioids to manage pain, particularly chronic pain. The HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesicspdf iconexternal icon emphasizes the importance of shared decision-making with patients, individualized and slow tapering, and integrated pain management and behavioral support for patients.

During this COCA Call, presenters will discuss the HHS guide and the advice it provides to clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid therapy for a patient with chronic pain.

At the conclusion of the session, the participant will be able to accomplish the following—

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Activity-specific Objectives
At the conclusion of the session, the participant will be able to accomplish the following—

  1. Identify criteria for considering reducing or discontinuing opioid therapy.
  2. Discuss important issues to consider prior to deciding to taper opioids.
  3. Describe steps to promote patient safety prior to initiating a taper.
  4. Identify practices associated with improved outcomes when opioids are tapered.
  5. Discuss management approaches to consider when there are challenges to tapering.

Admiral Brett P. Giroir, MD (USPHS)
Assistant Secretary for Health,
Department of Health and Human Services

Captain Deborah Dowell, MD, MPH (USPHS)
Chief Medical Officer
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention

Wilson M. Compton, MD, MPE
Deputy Director
National Institute on Drug Abuse

A few minutes before the webinar begins on Thursday, January 30, 2020, please click the link below to join the webinar:
https://zoom.us/j/316891067external icon

Or iPhone one-tap :
US: +16468769923,, 316891067# or +16699006833,, 316891067#

Or Telephone:
Dial (for higher quality, dial a number based on your current location):

US: +1 646 876 9923  or +1 669 900 6833

Webinar ID: 316 891 067

International numbers available: https://zoom.us/u/anixAVglVexternal icon

WC2922   0387-0000-19-202-L04-P (must be completed by March 2, 2020)
WD2922   0387-0000-19-202-H04-P (must be completed by March 3, 2022)

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians
  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees: Continuing Education (CE) is free.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-19-202-L04-P  and enduring 0387-0000-19-202-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:

In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.

Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

Page last reviewed: January 15, 2020